ingredients in glp 1 patches LBOYLOVE® GLP-1 GLP-1 Patches: What They Are

2025;38(2):e15702

Retatrutide metabolic benefits Retatrutide produces all of the metabolic benefits seen with Mounjaro plus additional improvements that appear unique to triple agonism: Blood sugar control: HbA1c reductions of 1.3% to 2.0% at doses of 4-12 mg in type 2 diabetes Blood pressure: Systolic blood pressure reduction of up to 14.0 mmHg at the highest dose (roughly double what Mounjaro achieves) Lipids: Non-HDL cholesterol and triglyceride reductions Prediabetes reversal: 72% of participants with prediabetes at baseline reverted to normoglycemia Inflammatory markers: Significant reductions in high-sensitivity C-reactive protein But the standout metabolic benefit, the one that has researchers most excited, is the effect on liver health

Reversible accumulation of cholesteryl esters in macrophages incubated with acetylated lipoproteins

A 2025 letter in Diabetes Care argues that microdosing via multidose pens can help patients who struggle with gastrointestinal side effects by allowing smaller, incremental dose adjustments, though the authors emphasize this is a pragmatic, clinician-directed strategy

Beginning July 1 and running through the end of 2027, a new pilot program will allow some Medicare Part D prescription plan members who want to shed excess pounds and maintain weight loss to get Wegovy injections and tablets, Foundayo tablets or the Zepbound KwikPen for a $50 monthly copay

Lukey MJ, Greene KS, Erickson JW, Wilson KF, Cerione RA